The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and
The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and
Swiss pharmaceutical giant Roche has finalised a £4.4 billion deal with Danish biotech firm Zealand Pharma to develop and commercialise a next-generation obesity treatment. The agreement focuses on Petrelintide, a






